https://scholars.lib.ntu.edu.tw/handle/123456789/113865
標題: | Risk of Pancreatic Cancer in Chronic Hepatitis B Virus Infection: Data from the Reveal-Hbv Cohort Study | 作者: | YANG, HWAI-I JEN, CHIN-LAN WANG, LI-YU YOU, SAN-LIN LU, SHENG-NAN CHEN, CHIEN-JEN |
關鍵字: | HBeAg;HBsAg;HBV DNA;hepatitis B;pancreatic cancer | 公開日期: | 2010 | 起(迄)頁: | 423-429 | 來源出版物: | Liver International | 摘要: | Background and aims: The relationship between the hepatitis B virus (HBV) and pancreatic cancer remains unclear. Because HBV has been isolated from pancreatic tissue, we hypothesized that HBV may play a role in the development of pancreatic carcinoma. Methods: This cohort was recruited between 1991 and 1992. Serum samples obtained at enrolment were tested for HBsAg and HBeAg by radioimmunoassay. Pancreatic cancer diagnosis was ascertained through data linkage with profiles of the National Cancer Registry and Death Certification System in Taiwan from 1 January 1991 to 31 December 2007. Multivariate-adjusted hazards ratios ( HRadj) with 95% confidence intervals (CI) were derived using Cox proportional hazards models. Results: In total 22 471 subjects were followed up for 342 186 person-years and 48 had pancreatic cancer. Chronic carriers of HBsAg had a significantly increased risk of pancreatic cancer showing an HRadj (95% CI) of 1.95 (1.01-3.78). This association was most striking in females, individuals <= 50 years, non- smokers and non-drinkers. The HRadj (95% CI) of developing pancreatic cancer was 5.73 (1.73-19.05) for HBeAg- seropositive carriers and 1.64 (0.79-3.42) for HBeAg- seronegative carriers compared with HBsAg-seronegative non- carriers. An increased risk of pancreatic cancer was observed for HBsAg-seropositives with HBV DNA >= 300 copies/ ml (HRadj, 2.44; 95% CI, 1.20-4.95), but not for HBsAg- seropositives with HBV DNA <300 copies/ml (HRadj, 0.64; 95% CI, 0.09-4.67) . Conclusions: In addition to the well- established risk of hepatocellular carcinoma, chronic HBV infection may be associated with an increased risk of pancreatic cancer. |
URI: | http://ntur.lib.ntu.edu.tw//handle/246246/235861 | DOI: | 10.1111/j.1478-3231.2009.02147.x | SDG/關鍵字: | hepatitis B surface antigen; hepatitis B(e) antigen; virus DNA; adult; aged; antigen detection; article; cancer diagnosis; cancer incidence; cancer registry; cancer risk; cohort analysis; death certificate; disease association; disease carrier; female; follow up; hazard ratio; hepatitis B; Hepatitis B virus; high risk patient; histopathology; human; liver cell carcinoma; major clinical study; male; pancreas cancer; proportional hazards model; radioimmunoassay; risk assessment; sex difference; Taiwan; Adult; Aged; Cohort Studies; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Pancreatic Neoplasms; Risk Factors |
顯示於: | 流行病學與預防醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。